![]() IR 783 structure
|
Common Name | IR 783 | ||
---|---|---|---|---|
CAS Number | 115970-66-6 | Molecular Weight | 749.35 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C38H46ClN2NaO6S2 | Melting Point | 209-212ºC(lit.) | |
MSDS | Chinese USA | Flash Point | N/A |
Functionalized graphene oxide-based thermosensitive hydrogel for magnetic hyperthermia therapy on tumors.
Nanotechnology 26 , 365103, (2015) A novel locally injectable, biodegradable, and thermo-sensitive hydrogel made from chitosan and β-glycerophosphate salt was prepared. It incorporated polyethylenimine (PEI)-modified super-paramagnetic graphene oxide (GO/IONP/PEI) as a form of minimally invasi... |
|
Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor.
Biomaterials 67 , 1-10, (2015) Brain tumors and brain metastases are among the deadliest malignancies of all human cancers, largely due to the cellular blood-brain and blood-tumor barriers that limit the delivery of imaging and therapeutic agents from the systemic circulation to tumors. Th... |
|
Preparation and evaluation of amoxicillin loaded dual molecularly imprinted nanoparticles for anti-Helicobacter pylori therapy.
Int. J. Pharm. 496 , 1006-14, (2015) This paper reports studies on preparation and evaluation of amoxicillin loaded dual molecularly imprinted nanoparticles (Amo/Dual-MIPs) designed for anti-H. pylori therapy. Both MNQA and AmoNa were chosen as templates to prepare Dual-MIPs using inverse microe... |
|
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
Theranostics 4 , 106-18, (2014) Complete removal of tumors by surgery is the most important prognostic factor for cancer patients with the early stage cancers. The ability to identify invasive tumor edges of the primary tumor, locally invaded small tumor lesions, and drug resistant residual... |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved